Taken together, our data showed that ARF6, NEDD9 and MT1-MMP are involved in regulation of cell migration and invasion in endometrial cancer cells and silencing of these proteins by progesterone and calcitriol-progesterone treatment could be a promising approach for therapeutic intervention. The gene discussed is ARF6; the disease is endometrial cancer.